TALTZ 40mg - 0.5ml (ixekizumab (TALTZ) PFS) 40mg - 0.5ml

TALTZ 40mg - 0.5ml (ixekizumab) is a prescription injection for managing immune-mediated inflammatory conditions. This prefilled syringe delivers 40mg of ixekizumab in 0.5ml. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using.

Strength

40mg - 0.5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ixekizumab, the active ingredient in TALTZ 40mg - 0.5ml, is used to treat moderate to severe plaque psoriasis in adults. It may also be prescribed for psoriatic arthritis and ankylosing spondylitis. This medication helps reduce inflammation and manage symptoms associated with these conditions. Patients often ask, 'what is ixekizumab used for' when considering treatment options.

Side Effects

TALTZ 40mg - 0.5ml works by targeting specific pathways in the immune system to reduce inflammation. Users may notice improvements in skin plaques and joint discomfort over time. Injection site reactions like redness or swelling can occur. Effects vary by individual, and consistent use is important for best results.

Precautions & Warnings

Keep TALTZ 40mg - 0.5ml refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Before using, inspect the syringe for particles or discoloration. Discuss your full medical history with a healthcare provider, including any infections or allergies. Proper disposal of used syringes is essential.

Avoid Interactions

TALTZ 40mg - 0.5ml may interact with live vaccines, increasing infection risk. Caution is advised when combining with other immunosuppressants or biologics. Alcohol and certain medications may affect how ixekizumab works. Always inform your doctor about all medications and supplements you are taking.

Frequently Asked Questions

TALTZ is given as a subcutaneous injection, typically every 4 weeks after an initial loading dose. Follow your healthcare provider’s instructions for proper technique.

Common side effects include injection site reactions, upper respiratory infections, and nausea. Serious reactions are rare but require immediate medical attention.

TALTZ is a prescription medication and may be available through licensed online pharmacies with a valid prescription.

Consult your healthcare provider before using ixekizumab if pregnant or planning pregnancy. The benefits and risks should be discussed case by case.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.